Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The matrix has a mind of its own
22 months since high of $13.00 on the cusp of turning it around and onto better times
“8:30a ET 10/11/2022 - PR Newswire
Concealed Weapon Detection Systems Market Expected To Reach $1.17 Billion By 2031
FinancialNewsMedia.com News Commentary -- Over the past few years due to global conflicts and the COVID virus, a lucrative market for the sale of concealed weapon detection systems has been created thanks to remarkable advancements made possible by the integration of sensors, imaging technologies, and actuators. The urgent need for contemporary, cutting-edge concealed weapon detectors has been brought on by growing terrorist threats that target public places for mass attacks. Without any physical contact between security personnel and the person being screened, security screening in conjunction with solutions for concealed weapons detection are used to find covert threats and illegal items. A recent report from Future Market Insights projected that the market for devices that detect concealed weapons is expected to grow from US$ 637.8 million in 2022 to US$ 1.17 billion by 2031. The market for hidden weapon detection systems is anticipated to expand at a strong CAGR of 6.9 percent between 2022 and 2031. The report said: "There is a critical need for concealed weapon detection systems in the aviation industry, the government sector, and commercial spaces including educational institutions, banks, and shopping centers because anti-social groups pose a threat to public safety. Terahertz body scanners can recognize and precisely locate dangers, such as concealed weapons and contraband, that are concealed in bags or beneath a person's clothing... The rise of cross-border terrorism and an increasing number of terrorist outfits have given every government a reason to invest in the best and the most advanced concealed weapon detection technologies." Active companies in the markets this week include Liberty Defense Holdings Ltd. (OTCQB: LDDFF) (TSX-V: SCAN)
Future Market Insights continued: "High efficiency sensing technologies are required for effective security screening and weapon detection at high public throughput locations like courthouses, airports, museums, and prisons. Companies are being driven to develop and incorporate high speed sensors into security screening solutions by the demand for effective concealed weapon detection. Configurable... body scanning systems have been widely used globally due to the urgent need for security screening with concealed weapon detection at ports and borders amid escalating political unrest. It is possible to combat illegal activities and terrorism at airports, train stations, metro stations, national borders, and other locations by integrating autonomous and covert sensing resources. During the forecast period, high-quality, autonomous sensing equipment integration is anticipated to significantly contribute to the growth of the global market for concealed weapon detection systems."
Liberty Defense Holdings Ltd. (OTCQB: LDDFF) (TSXV: SCAN) BREAKING NEWS: Liberty Defense Receives $1,750,000 Contract Award from TSA for Development of AIT Screening Upgrades - Liberty to develop a retrofit kit for improved airport security checkpoint passenger screening with next generation, advanced imaging technology (AIT) - Liberty Defense Holdings Ltd. (FRANKFURT: LD2A) ("Liberty" or the "Company"), a leading technology provider of detection solutions for concealed weapons and threats, is pleased to announce that it has received an award from the Transportation Security Administration (TSA) for $1.75M for the development of a prototype High-Definition Advanced Imaging Technology (HD-AIT) upgrade kit for testing on an AIT passenger screening system.
The HD-AIT next-generation people screening technology platform for threat detection uses high-definition imaging and Artificial Intelligence, resulting in greater detection, with a lower false alarm rate for a better passenger experience.
The TSA, an agency of the U.S. Department of Homeland Security, is responsible for all security screening conducted at airports in the United States. TSA's On-Person Screening program aims to detect a growing range of threats, with fewer false alarms and less physical contact. In addition to enhanced detection, the HD-AIT body scanners are anticipated to help improve passenger experience and move people through the checkpoint more seamlessly.
"We are excited to partner with TSA on this critical initiative to help develop the next generation of passenger screening," says Liberty CEO Bill Frain. "Liberty shares the same mission as TSA for On-Person Screening and deploying future state capability, with the focus on detecting more threats and providing an overall better experience for the traveling public."
Liberty previously licensed a millimeter wave-based, High-Definition Advanced Imaging Technology (HD-AIT) body scanner and a shoe screener technology in March of 2021. Both technologies were developed by researchers at the Pacific Northwest National Laboratory (PNNL), funded by U.S. Department of Homeland Security Science and Technology Directorate (DHS S&T) on behalf of the Transportation Security Administration mission. Liberty is now developing the technology in house with its experienced team of engineers. “
“9:20a ET 10/11/2022 - Benzinga
Blue Water Vaccines Announces Plans To Evaluate Efficacy Of Streptococcus pneumoniae Vaccine Candidate Against Pneumococcal Pneumonia At The World Vaccine Congress In Barcelona
Blue Water Vaccines Inc. ("BWV" or "Blue Water Vaccines" or the "Company"), a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced plans to investigate the ability of BWV-201, a Streptococcus pneumoniae vaccine candidate for acute otitis media ("AOM") prevention, to also protect against non-invasive pneumococcal pneumonia at the World Vaccine Congress in Barcelona.
While Streptococcus pneumoniae is commonly found in the nose and throat of healthy individuals, overgrowth and spread of the bacteria can result in pneumococcal disease. Non-invasive forms of pneumococcal disease include AOM, sinusitis, and pneumococcal pneumonia, while invasive forms include bacteremia, sepsis, and pneumococcal meningitis. BWV's new development plan aims to assess the efficacy of BWV-201 in protecting individuals against non-invasive pneumococcal pneumonia.
BWV-201 is a live attenuated bacterial vaccine candidate developed for the prevention of AOM in children caused by Streptococcus pneumoniae. New data, based on experiments at St. Jude Children's Research Hospital, suggests that BWV-201 may also provide protection against pneumococcal pneumonia by limiting the ability of Streptococcus pneumoniae to infect the lungs.
While conjugate and polysaccharide vaccines are available to protect against pneumococcal disease, protection is mainly limited to invasive disease. Efficacy rates of these vaccines against pneumococcal pneumonia are historically only between 0% and 50%, as these vaccines are administered intramuscularly and elicit a strong systemic response, but poor protection at the mucosal surface where pneumonia infection begins. Additionally, these vaccines only provide protection against serotypes included in the vaccine, ranging from 13 to 23 serotypes. By administering the modified live bacteria intranasally, BWV-201 is designed to elicit a strong mucosal immune response, regardless of capsular polysaccharide serotype.
"While current pneumococcal vaccines have demonstrated excellent efficacy against invasive pneumococcal disease historically, pneumococcal pneumonia remains a significant unmet medical need," said Joseph Hernandez, Chairman and Chief Executive Officer of Blue Water Vaccines. "With this new data, we believe our vaccine can provide protection across all Streptococcus pneumoniae strains and eliminate the need for antibiotic treatment associated with pneumococcal pneumonia. We are excited to further develop BWV-201 for this new indication and look forward to addressing this need."
According to the Centers for Disease Control and Prevention, non-invasive pneumococcal pneumonia causes an estimated 150,000 hospitalizations each year in the United States alone. Despite vaccination efforts with traditional pneumococcal vaccines, the American Lung Association reports that adults over 65 years old are at 6.1 times greater risk for pneumonia infection and over 10 times more likely to be hospitalized with pneumococcal pneumonia versus healthy adults.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.”
Gap filled at 1.71, big chance to go higher now because of that and the charts imo
This is all build up to when the baby formula is ready, these are singles and doubles that keep the game even or slightly ahead per day, until one day goes rocket to the moon imo.
“9:32a ET 7/19/2022 - Benzinga
WidePoint Says Awarded More than $53.2M In Contracts In Q2 2022
https://www.accesswire.com/709024/WidePoint-Awarded-More-than-532-Million-in-Contracts-During-the-Second-Quarter-of-2022
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.”
“10:27a ET 7/13/2022 - Dow Jones
WidePoint Shares Climb 13% on U.S. Coast Guard Task Order
By Kathryn Hardison
WidePoint Corp. shares rose 13%, to $2.66, on Wednesday after it said the U.S. Coast Guard awarded it a task order for cellular wireless managed services until 2026 with an award of up to $73.4 million.
The task order has an obligated base period of performance of six months with funding of $7.9 million. It spans from May 1 through Oct. 31, 2026.
WidePoint focuses on identity and access management, mobility managed services, telecom management, information technology as a service, cloud security and digital billing and analytics.
Shares were down 32% for the year.
Write to Kathryn Hardison at kathryn.hardison@wsj.com
(END) Dow Jones Newswires
July 13, 2022 10:27 ET (14:27 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.”
Outstanding Shares
8,733,938
08/15/2022
SP is ridiculously undervalued when applying the above numbers imo.
Major revenue opportunity in China for baby products
The NHL begins
15 day Update on this possible:
“10:33a ET 9/26/2022 - Dow Jones
Inpixon Shares Rise 26% After Deal to Sell Enterprise Apps Business
By Chris Wack
Inpixon shares were up 26% to 15 cents Monday after the company said it signed a definitive merger agreement to sell its enterprise apps business to KINS Technology Group Inc.
The deal includes the enterprise apps business' workplace experience technologies, indoor mapping, events platform, augmented reality and related business solutions.
The transaction will be structured as a business combination with Inpixon's newly formed CXApp Holding Corp. subsidiary, and is expected to result in Inpixon stockholders receiving shares in KINS valued at $69 million.
Inpixon said the transaction is expected to provide its enterprise apps business with greater capital and operational resources, a new executive management team and board expertise to accelerate growth.
Following the closing of the transaction, CXApp will be a wholly owned subsidiary of KINS, and the combined business will be listed on the Nasdaq Capital Market.
The proposed transaction is expected to be completed in the fourth quarter of 2022.
Write to Chris Wack at chris.wack@wsj.com
(END) Dow Jones Newswires
September 26, 2022 10:33 ET (14:33 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.”
Let’s see if the buyback begins to assist shareholders
Months of patience about to surge this week imo
B Square
2 x 2
‘22
Months of patience about to surge this week imo
B Square
2 x 2
‘22
“This prospectus relates to the offer and resale of up to an aggregate of 8,876,705 shares of common stock, par value $0.00001 per share (“Placement Shares”), of Blue Water Vaccines Inc. (“Blue Water,” “BWV,” “the Company,” “we,” “us” or “our”) held by selling stockholders, consisting of (a) 1,350,000 Placement Shares, (b) 220,997 Placement Shares (“Wainwright Warrant Shares”) issuable upon exercise of the warrants (the “Wainwright Warrants”) issued to H.C. Wainwright & Co., LLC, or its designees, in a private transaction on August 22, 2022 (the “Private Placement”), (c) 2,333,280 Placement Shares (“Prefunded Warrant Shares”) issuable upon exercise of the pre-funded warrants (the “Prefunded Warrants”) issued to the selling stockholders in the “Private Placement” determined as if the outstanding warrants were exercised in full as of the trading day immediately preceding the date this registration statement was initially filed with the SEC, each as of the trading day immediately preceding the applicable date of determination and all subject to adjustment as provided in the registration rights agreement and (d) 4,972,428 Placement Shares (“Preferred Investment Option Shares,” together with the Prefunded Warrant Shares, the “Warrant Shares”) issuable upon exercise of the preferred investment options (the “Preferred Investment Options”, together with the Prefunded Warrants, the “Warrants”), issued to the selling stockholders in the Private Placement determined as if the outstanding Preferred Investment Options were exercised in full as of the trading day immediately preceding the date this registration statement was initially filed with the SEC, each as of the trading day immediately preceding the applicable date of determination and all subject to adjustment as provided in the registration right agreement, all of which were acquired by the selling stockholders in. The holders of the Placement Shares, the Warrant Shares and the Warrants are each referred to herein as a “Selling Stockholder” and collectively as the “Selling Stockholders.”
This prospectus also covers any additional shares of common stock that may become issuable upon any anti-dilution adjustment pursuant to the terms of the Warrants issued to the Selling Stockholders by reason of stock splits, stock dividends, and other events described therein.
The Selling Stockholders, or their respective transferees, pledgees, donees or other successors-in-interest, may sell the Placement Shares or the Warrant Shares through public or private transactions at prevailing market prices, at prices related to prevailing market prices or at privately negotiated prices. The Selling Stockholders may sell any, all or none of the securities offered by this prospectus, and we do not know when or in what amount the Selling Stockholders may sell their Placement Shares or Warrant Shares hereunder following the effective date of this registration statement. We provide more information about how a Selling Stockholder may sell its Placement Shares or Warrant Shares in the section titled “Plan of Distribution” on page 165.
We are registering the Placement Shares and Warrant Shares on behalf of the Selling Stockholders, to be offered and sold by them from time to time. We will not receive any proceeds from the sale of our common stock by the Selling Stockholders in the offering described in this prospectus. We cannot predict when and in what amounts or if the Warrants will be exercised. We have agreed to bear all of the expenses incurred in connection with the registration of the Placement Shares and the Warrant Shares. The Selling Stockholders will pay or assume discounts, commissions, fees of underwriters, selling brokers or dealer managers and similar expenses, if any, incurred for the sale of the Placement Shares and the Warrant Shares.
We are an “emerging growth company” and a “smaller reporting company” as such terms are defined under federal securities laws, and, as such have elected to take advantage of certain reduced public company reporting requirements for this prospectus and may elect to do so in future filings.
This prospectus describes the general manner in which the Placement Shares and the Warrant Shares may be offered and sold.
If necessary, the specific manner in which the Placement Shares and the Warrant Shares may be offered and sold will be described in a supplement to this prospectus.
Our shares of common stock have experienced extreme volatility in market prices and trading volume since listing. From February 18, 2022 (the date our shares were initially listed on Nasdaq) to the date hereof, the market price of our common stock has fluctuated from an intra-day low on Nasdaq of $1.80 on July 15, 2022 to an intra-day high of $90.90 per share on February 22, 2022. By comparison, our initial public offering, which closed on February 23, 2022, was conducted at $9.00 per share. During this time, we have made six announcements regarding certain research developments and partnerships for our vaccine candidates. Notwithstanding the foregoing, since our initial public offering on February 18, 2022, there were no material recent publicly disclosed changes in the financial condition or results of operations of the Company, such as our earnings or revenue, that are consistent with or related to the changes in our stock price. The trading price of our common stock has been, and may continue to be, subject to wide price fluctuations in response to various factors, many of which are beyond our control, including those described under the heading “Risk Factors” beginning on page 14 of this prospectus.
Investing in our common stock involves a high degree of risk. Please read “Risk Factors” beginning on page 14 of this prospectus.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.
The date of this prospectus is September 19, 2022
”
1.40 gap fill by November 2 imo
Good will hunting was a love story, will check back on Valentines Day at 2.76 per share gap fill imo
Other correlations:
Good Will, Hunter Biden
Submarine movies predicting the future:
Hunt for Red October
K-19 (11-‘19, Covid-19) the Widowmaker. (2002)
Other movies predicting disaster and Russian involvement:
The Sum of All Fears (2002)
Pandemic and Nuclear War with Russia predicted in movies, sound familiar? (9/11/01)
Looks like .06 by October 21st, 1/25/21 gap fill imo
No planned launches till 2023, chart indicates tomorrow as a possible opportunity, updates on the last two stages of the investigation appear to be the only possible catalysts though, speculative imo
Trading at a pre-split equivalent of .0745
Trading at a pre-split equivalent of .0745
Big week possible , buyback, clinics, legalization perfect storm brewing
January 7 next opportunity imo 6 month consolidation
ForW
For23
For ‘23
That is a Saturday so the fourth trading day would be the 6th.
10/22 imo, 1 year consolidation completes
1.71 cup and handle opportunity with follow through, chance to uplist
Chart is primed and ready for launch, one of the most favorable charts currently that I know of imo
3 months to go till January 11 chart opportunity imo
I am going to wait for November just in case I subliminally was talking about 2022 which consciously I wasn’t at the time, a Freudian prediction, the problem may be that the R/S may cause the increase artificially:
“StockLogistics
Re: JMMatthews post# 1630
Tuesday, 09/28/2021 7:24:56 AM
They invested in the Hunt in late September as in “The hunt for RED October” movie, Michael Bay (wash out, flood of selling in October due to warrant issuance) is a movie director. Going under 1.00 like a submarine seeking the depths of the ocean, in November it will start to turn up again as filings for Q3 near. Then it will go from .20 back to $18 dollars in November. All imo“
Long time usually to get from dilution to acquisition to earnings greater than the dilution, GLTA.
70k x 7000 tons is 490 million, so the 400 million would be for the 6000 tons, in theory. The chart says to wait till 2/11/23 to buy, makes sense since the refinery goes live in Spring. Could it increase in short term bursts, anything is possible.
This stock is called “snow” and SP increases from May till early December, before winter begins in the U.S.., it appears. That is some sort of counter trend to the idea of snowing.
110 million outstanding and 10 million in annual sales, lucky that it isn’t a .10 stock imo with that ratio of sales to OS.
“5:16p ET 8/11/2022 - Benzinga
Hall Of Fame Resort Q2 Sales $2.70M Miss $3.50M Estimate
Hall Of Fame Resort (NASDAQ:HOFV) reported quarterly sales of $2.70 million which missed the analyst consensus estimate of $3.50 million by 22.86 percent. This is a 14.21 percent increase over sales of $2.36 million the same period last year.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.”
Jake Paul’s in-game prizing capabilities for his App are already patented by Versus Systems; therefore a license from VS is required to operate that App without an injunction being filed imo.
“6:30p ET 9/6/2022 - Benzinga
Jake Paul Launches Betr App, Potentially Making Him (And You) Richer
Jake Paul, former Walt Disney actor and current YouTube star-turned-boxer, has launched micro-betting sports platform Betr alongside Joey Levy, founder of Simplebet, after rasing $30 million in a Series A funding round with investments from rapper Travis Scott andpro football players Ezekiel Elliott, Richard Sherman and Dez Bryant.
The Series A round was followed up by a Series A1 round in which an additional $20 million was raised.
The app's main goal is to simplify the process of sports betting by allowing users to predict the results of every sporting event's individual moments, such as pitches and at-bats in Major League Baseball games and every play and drive in all National Football League games.
The app is available for free download; users are supplied gambling coins that can be redeemed for actual prizes if bets are won.Read more: Kim Kardashian, Ashton Kutcher & Chris Paul: Could Peloton Shares Ride A Celebrity Wave?
While the company's app presently does not support the use of real money, it has applied for an Ohio betting license and announced a partnership with Hall of Fame Resort & Entertainment Co (NASDAQ: HOFV) that will allow it to launch the cash-based version once the state has given its approval.”
“7:08a ET 7/26/2022 - Benzinga
U.S. Patent Office Grants New Patent Claims For Versus Systems' Streaming Media Rewards Platform
Versus Systems Inc. ("Versus" or the "Company") (NASDAQ:VS) announces that, pursuant to a Versus filing made in 2019, the U.S. Patent and Trademark Office (USPTO) has now allowed 20 new claims associated with a new patent titled "MANAGING IN-CONTENT CHALLENGES FOR MULTI-PLAYER GAMES." The USPTO has now issued U.S. Patent No. 11,376,498 to Versus to cover games and challenges that produce real world rewards inside of apps and streaming media.
Versus' new patented claims protect several methods for managing first and second-screen games inside of apps, television broadcasts, and streaming media, with a focus on how to provide different digital and physical prizes to different players based on their performance in the games and eligibility criteria such as age and location. This IP could allow content creators and distributors new ways to help audiences earn rewards while watching and interacting with their favorite shows, including live sports, game-streams, and reality TV. This technology has the potential to dramatically increase the potential number of participants in sweepstakes, tournaments, and rewards-based competitions. Versus will be using its patented technologies in-venue, at NFL, NHL, NBA, NCAA, and other sporting events and, beginning in Q4 of this year, in Over-The-Top (OTT) television and streaming media.
Versus' growing patent portfolio now includes multiple granted US and international patents, with dozens of claims around the management of prizing in games, dynamic regulatory compliance, single and multiplayer prizing, competitive balance, and rewards in streaming media.
In addition to these new claims granted by the USPTO and their other issued patents, Versus continues to actively develop and file patent claims for new technologies focused on prizing and rewards inside interactive media, securing intellectual property protection accordingly, both in the United States and other Patent Cooperation Treaty countries.
"Versus is very proud of its growing patent portfolio around in-game rewards. We are creating innovative, unique technologies for both content creators and audiences," said Matthew Pierce, Founder and CEO of Versus Systems. "The streaming media landscape is changing so fast - from Disney to Amazon to Discovery to the evolving college football landscape, fans should expect a better experience than traditional TV commercials. Content, even branded, sponsored, and ad-supported content, should be more personal, more contextual, and more rewarding. Audiences should be able to earn rewards and prizes that they care about while watching their favorite content. These patents help with that. Our whole portfolio does. We want to make things more fun, and we're eager to use this patented technology to do that."
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.”
Versus owns the patent for this technology for in game prizing and Jake Paul should license the patent from VS:
“6:30p ET 9/6/2022 - Benzinga
Jake Paul Launches Betr App, Potentially Making Him (And You) Richer
Jake Paul, former Walt Disney actor and current YouTube star-turned-boxer, has launched micro-betting sports platform Betr alongside Joey Levy, founder of Simplebet, after rasing $30 million in a Series A funding round with investments from rapper Travis Scott andpro football players Ezekiel Elliott, Richard Sherman and Dez Bryant.
The Series A round was followed up by a Series A1 round in which an additional $20 million was raised.
The app's main goal is to simplify the process of sports betting by allowing users to predict the results of every sporting event's individual moments, such as pitches and at-bats in Major League Baseball games and every play and drive in all National Football League games.
The app is available for free download; users are supplied gambling coins that can be redeemed for actual prizes if bets are won.Read more: Kim Kardashian, Ashton Kutcher & Chris Paul: Could Peloton Shares Ride A Celebrity Wave?
While the company's app presently does not support the use of real money, it has applied for an Ohio betting license and announced a partnership with Hall of Fame Resort & Entertainment Co (NASDAQ: HOFV) that will allow it to launch the cash-based version once the state has given its approval.
The coins that users can spend on a whim in the app is reflective of Paul, who has been known to place public bets on fighters that he intends to get into the ring with.
After a successful year both inside and outside the ring, he disclosed his net worth in excess of $100 million in an interview with Fox Business.
He reportedly earned $40 million in 2021 after twice defeating Tyron Woodley and Ben Askren.
After defeating Askren, Paul earned an estimated $10 million. He next competed against Woodley on Showtime pay-per-view, earning an estimated $15 million.
Follwing the Askren fight, a bout with Tommy Fury fell through. Paul fought Woodley again. Paul defeated Woodley in the rematch, earning him an additional $15 million.
The former YouTube star said that he also profited from trading NFTs and cryptocurrencies.
Courtesy photo.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.”
Strategic investment, now let’s see the product etc and start to make some money, chart is ready for launch
Time for this mining operation to emerge as a major lithium player in the west between 1 and 2 dollars a share like other similar mining operations
Macd on one month about to cross lower unless they have premarket news, many will sell premarket without news so if they have something releasing it premarket would be best for loyal shareholders who would miss out on a new release later in the session.
Maybe they announce something soon to take advantage of the low float, if their enterprise apps business is sold for 69 million then that 69 million is cash value for the company divided by OS to achieve proper Shareprice imo.
I’m a fan of Tyson , Biden’s announcement offset the news below, I wish I had bought it last week because the chart said to buy and I missed the opportunity.
“2:56p ET 9/8/2022 - MarketWatch
Quebec and Alberta provinces reportedly won't allow sales of Mike Tyson's cannabis by Hexo”
“Electra will supply 1,000 tonnes of cobalt contained in a cobalt sulfate product in 2023 and a further 3,000 tonnes in each of 2024 and 2025 under an agreed pricing mechanism.”
1000 x 55000 is 55 million, I think they expect the price of cobalt to increase to 70000 per ton in 2023 as demand increases so the 70 million would be for 2023 only, imo. As for the price drop these past two days, the chart has a gap at 2.90 which i expect to close by 10/21/22. The market has too much fear in it and tax selling season means to me to look towards the lower bollinger band and reversals for opportunities.
Anytime a company offers new shares and/or warrants they are diluting their company’s value, also known as theft from current shareholders, hence the price drop, i personally don’t understand why the price rose to 2.00, there was zero news that I found convincing or enticing to consider this stock a viable and credible company. All imo.
It closed below the lower bollinger band on 9/14/22, the reversal wasn’t convincing and I wish I had waited for a more convincing reversal, the numbers for this stock are impressive but the market is what it is… full of tards… so I’ll wait for another close below the lower bollinger band prior to getting in again, right now that would be .14 a share.